TGA Testing Exposes Serious Quality Failures in Unapproved Peptides: Products Do Not Contain Ingredients Claimed on Labels; Global Drug Regulators Urged to Expand Surveillance and Laboratory Testing
DO
By Daniel Okafor · Regulatory Correspondent
Nov 5 22:47 ETSource: drugscontrol.org
From the source
Read at drugscontrol.orgTGA Testing Exposes Serious Quality Failures in Unapproved Peptides: Products Do Not Contain Ingredients Claimed on Labels; Global Drug Regulators Urged to Expand Surveillance and Laboratory Testing
